Healthcare workers' role in keeping MMR vaccination uptake high in Europe: A review of evidence

Eurosurveillance

Volumn 17, Issue 26, 2012, Pages

  Simone, B ^a,b   Carrillo Santisteve, P ^a   Lopalco, P L ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ALTERNATIVE MEDICINE; ATTITUDE TO HEALTH; DATA EXTRACTION; DECISION MAKING; DISEASE CONTROL; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HOMEOPATHY; HUMAN; MEASLES; MEASLES VACCINATION; REVIEW;

EID: 84863558350     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. World Health Organization (WHO). Measles fact sheet N°286. Geneva: WHO; Apr 2012. Available from: http://www.who.int/mediacentre/factsheets/fs286/en/index.html
2. Strebel PM, Papania MJ, Dayan GH, Halsey NA. Measles vaccines. In: Plotkin S, Orenstein W, Offit P. Vaccines. 5th ed. Saunders Elsevier; 2008. p. 353-98.
3. National Health Service (NHS). Complications of measles. [Accessed 23 Apr 2012]. Available from: http://www.nhs.uk/Conditions/Measles/Pages/Complications.aspx
4. DrugsUpdate. com. Tresivac from Serum Institute [Vaccine, MMR]. [Accessed 23 April 2012]. Available from: http://www.drugsupdate.com/brand/generic/Vaccine,%20MMR/4086
5. European Centre for Disease Prevention and Control (ECDC). Vaccination schedules. Stockholm: ECDC. [Accessed 23 Apr 2012]. Available from: http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/schedules.aspx
6. World Health Organization (WHO) Regional Office for Europe. Eliminating measles and rubella. Framework for the verification process in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2012. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/158304/EURO_MR_Elimin_Verification_Processv2.pdf
7. Lopalco PL, Sprenger M. Do European doctors support measles, mumps, rubella vaccination programmes enough? Euro Surveill. 2011;16(39):pii=19979. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19979
8. Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K; EUVAC. NET Group. Measles in Europe: an epidemiological assessment. Lancet. 2009;373(9661):383-9.
9. European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO). September 2011. Stockholm: ECDC; 2011. Available from: http://www.ecdc.europa.eu/en/publications/Publications/111018_EMMO_SEPT_2011.pdf
10. van Esso D, del Torso S, Hadjipanais A, Biver A, Jaeger-Roman E, Wettergren B, et al. Paediatric primary care in Europe: variation between countries. Arch Dis Child. 2010;95(10):791-5.
11. VENICE Working Group. Report on first Survey of immunisation programs in Europe. VENICE; 2007. Available from: http://venice.cineca.org/Report_II_WP3.pdf
12. National Institutes of Health (NIH). Measles database. Bethesda, MD: NIH. [Accessed 23 April 2012]. Available from: http://science.education.nih.gov/supplements/nih1/diseases/activities/activity5_measles-database3.htm
13. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637-41.
14. Retraction-Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375(9713):445. Retraction of:
15. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Lancet. 1998;351(9103):637-41.
16. American Academy of Pediatrics (AAP). Facts for parents about vaccine safety. Elk Grove Village, IL: American Academy of Pediatrics; March 2008. Press release. Available from: http://www2.aap.org/advocacy/releases/autismfactsforparents.pdf
17. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353(9169):2026-9.
18. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners a time-trend analysis. West J Med. 2001;174(6):387-90.
19. Return of the measles parties (or why parents fear MMR jabs). Daily Mail. 15 Feb 2000. Available from: http://www.whale.to/vaccines/measles7.html
20. Simpson N, Lenton S, Randall R. Parental refusal to have children immunised: extent and reasons. BMJ. 1995;310(6974):227.
21. Burton-Jeangros C, Golay M, Sudre P. [Compliance and resistance to child vaccination: a study among Swiss mothers]. Rev Epidemiol Sante Publique. 2005;53(4):341-50. French.
22. Anastasi D, Di Giuseppe G, Marinelli P, Angelillo IF. Paediatricians knowledge, attitudes, and practices regarding immunizations for infants in Italy. BMC Public Health. 2009;9:463.
23. Angelillo IF, Ricciardi G, Rossi P, Pantisano P, Langiano E, Pavia M. Mothers and vaccination: knowledge, attitudes, and behaviour in Italy. Bull World Health Organ. 1999;77(3):224-9.
24. Commité français d'éducation pour la santé. Vaccination rougeole, oreillons, rubéole. Des inégalités persistantes. [French health education committee. Measles, mumps and rubella vaccination: persisting inequalities]. Commité français d'éducation pour la santé; Sep 2001. Dossier de presse. Available from: http://www.inpes.sante.fr/70000/dp/01/dp010907.pdf
25. Hak E, Schönbeck Y, De Melker H, Van Essen GA, Sanders EA. Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program. Vaccine. 2005;23(24):3103-7.
26. Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ. 2001;322(7278):82-5.
27. Smith A, McCann R, McKinlay I. Second dose of MMR vaccine: health professionals' level of confidence in the vaccine and attitudes towards the second dose. Commun Dis Public Health. 2001;4(4):273-7.
28. Cotter S, Ryan F, Hegarty H, McCabe TJ, Keane E. Immunisation: the views of parents and health professionals in Ireland. Euro Surveill. 2003;8(6):pii=416. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=416
29. Rotily M, Guagliardo V, Fontaine D, Garros B, Mayer C, Arrighi J, et al. Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors. Rev Epidemiol Sante Publique. 2001;49(4):331-41. French.
30. Theeten H, Hens N, Vandermeulen C, Depoorter AM, Roelants M, Aerts M, et al. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey. Vaccine. 2007;25(26):4940-8.
31. Posfay-Barbe KM, Heininger U, Aebi C, Desgrandchamps D, Vaudaux B, Siegrist CA. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics. 2005;116(5);e623-33.
32. Trier H. Doctors' attitudes and MMR-vaccination. Scand J Prim Health Care. 1991;9(1):29-33.
33. Ernst E. The attitude against immunisation within some branches of complementary medicine. Eur J Pediatr. 1997;156(7):513-5.
34. Ernst E, White AR. Homoeopathy and immunization. Br J Gen Pract. 1995;45(400):629-30.
35. Schmidt K, Ernst E. Aspects of MMR. Survey shows that some homoeopaths and chiropractors advise against MMR. BMJ. 2002;325(7364):597.
36. Lehrke P, Nuebling M, Hofmann F, Stoessel U. Attitudes of homoeopathic physicians towards vaccination. Vaccine. 2001;19(32):4859-64.
37. McMurray R, Cheater FM, Weighall A, Nelson C, Schweiger M, Mukherjee S. Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions. Br J Gen Pract. 2004;54(504):520-5.
38. Ramsay ME, Yarwood J, Lewis D, Campbell H, White JM. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract. 2002;52(484):912-6.
39. Pareek M, Pattison HM. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Br J Gen Pract, 2000;50(461):969-71.
40. Coniglio MA, Platania M, Privitera D, Giammanco G, Pignato S. Parents' attitudes and behaviours towards recommended vaccinations in Sicily, Italy. BMC Public Health. 2011;11:305.
41. Impicciatore P, Bosetti C, Schiavio S, Pandolfini C, Bonati M. Mothers as active partners in the prevention of childhood diseases: maternal factors related to immunization status of preschool children in Italy. Prev Med. 2001;31(1):49-55.
42. Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24(37-39):6351-5.
43. Dannetun E, Tegnell A, Hermansson G, Giesecke J. Parents' reported reasons for avoiding MMR vaccination. A telephone survey. Scand J Prim Health Care. 2005;23(3):149-53.
44. Stefanoff P, Mamelund SE, Robinson M, Netterlid E, Tuells J, Bergsaker MA, et al. Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC). Vaccine. 2010;28(35):5731-7.
45. Swennen B, Van Damme P, Vellinga A, Coppieters Y, Depoorter AM. Analysis of factors influencing vaccine uptake: perspectives from Belgium. Vaccine. 2001;20 Suppl 1:S5-7; discussion S1.
46. Smith A, Yarwood J, Salisbury DM. Tracking mothers' attitudes to MMR immunisation 1996-2006. Vaccine. 2007;25(20):3996-4002.
47. Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Long SJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine. 2010;28(26):4235-48.
48. Hilton S, Petticrew M, Hunt K. Parents' champions vs. vested interests: who do parents believe about MMR? A qualitative study. BMC Public Health. 2007;7:42.
49. Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine. 2006;24(2):177-84.
50. Ciofi degli Atti ML, Rota MC, Bella A, Salmaso S; ICONA Study Group. Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine. 2004;22(31-32):4351-7.
51. World Health Organization (WHO) Regional Office for Europe. Resolution. Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region. Regional Committee for Europe Sixtieth session. Moscow, 13-16 September 2010. Copenhagen: WHO Regional Office for Europe; 16 Sep 2010. Available from: http://www.euro.who.int/__data/assets/pdf_file/0016/122236/RC60_eRes12.pdf
52. Impfstatus sowie Einstellung und Verhalten von Hebammen zu Impfungen-Ergebnisse einer Querschnittsstudie. [Vaccination status, Perception and Attitude of midwifes towards vaccination-results of a cross sectional study]. Epidemiologisches Bulletin. 2008;21:163-72. German. Available from: http://edoc.rki.de/documents/rki_fv/reYq8gLvybNOo/PDF/24iEyYcdYnnL2Y.pdf
53. European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO). Issue 8: 21 February 2012. Stockholm: ECDC; 2012. Available from: http://ecdc.europa.eu/en/publications/Publications/SUR_EMMO_European-monthly-measles-monitoring-February-2012.pdf
54. Council of the European Union. Council conclusions on childhood immunisation: successes and challenges of European childhood immunisation and the way forward. Luxembourg: Council of the European Union; 6 Jun 2011. Available from: http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/122391.pdf
55. Centers for Disease Control and Prevention (CDC). Progress toward elimination of measles from the Americas. MMWR Morb Mortal Wkly Rep. 1998;47(10):189-92. Available from: http://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4710.pdf
56. de Quadros CA, Hersh BS, Nogueira AC, Carrasco PA, da Silveira CM. Measles eradication: experience in the Americas. MMWR Morb Mortal Wkly Rep. Supplement. 1999;48(SU01):57-64. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/su48a12.htm